LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

Home・Akciju saraksts・Microbot Medical Inc

Microbot Medical Inc

Slēgts

2.21 -8.3

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.21

Max

2.41

Galvenie mērījumi
By Trading Economics
Ienākumi	-77K -3.6M
Peļņas marža	-4,038.095
Darbinieki	20
EBITDA	-79K -3.6M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+263.07% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	18M 158M
Iepriekšējā atvēršanas cena	10.51
Iepriekšējā slēgšanas cena	2.21

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 15. dec. 17:39 UTC

Galvenie tirgus virzītāji

Vanda Pharmaceuticals Rises on FDA Biologics License Application

2025. g. 15. dec. 23:44 UTC

Tirgus saruna

Gold Steady Ahead of U.S. Employment Report -- Market Talk

2025. g. 15. dec. 23:38 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 15. dec. 23:38 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

2025. g. 15. dec. 22:19 UTC

Tirgus saruna

Clean-Energy Project Developers Benefit From 'Deep Buyer Universe' -- Market Talk

2025. g. 15. dec. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 15. dec. 21:42 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Modest Valuation, a Signal for a Warner Bros. Sale -- Barrons.com

2025. g. 15. dec. 21:32 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Modest Valuation, Puts Warner Bros. Discovery in Focus -- Barrons.com

2025. g. 15. dec. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

iRobot Files for Bankruptcy After Amazon Was Forced to Scrap Its Deal to Buy the Roomba Maker -- Barrons.com

2025. g. 15. dec. 21:26 UTC

Iegādes, apvienošanās, pārņemšana

Commercial Metals Completes Acquisition of Foley Products for $1.84B >CMC

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Reserves Right to Make Further Proposal If Circumstances Change

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Does Not Intend to Submit Revised Takeover Proposal For Predictive

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Notes Predictive Shares Trade at Discount to Value Implied By Perseus Proposal

2025. g. 15. dec. 21:22 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Believes Revised Robex Merger Inferior to Its Own Takeover Proposal

2025. g. 15. dec. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Commercial Metals Completes Acquisition Of Foley Products Company >CMC

2025. g. 15. dec. 21:15 UTC

Iegādes, apvienošanās, pārņemšana

ServiceNow Completes Acquisition Of Moveworks >NOW

2025. g. 15. dec. 21:00 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

2025. g. 15. dec. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

2025. g. 15. dec. 20:36 UTC

Tirgus saruna

Oil Futures Fall Further on Oversupply Concerns -- Market Talk

2025. g. 15. dec. 20:31 UTC

Tirgus saruna

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

2025. g. 15. dec. 20:27 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

ServiceNow's Acquisition Streak Could Cause Investor Angst -- Market Talk

2025. g. 15. dec. 20:15 UTC

Tirgus saruna

El Buen Fin Helps Lift Mexican November Retail Sales -- Market Talk

2025. g. 15. dec. 19:22 UTC

Tirgus saruna

Gold and Silver Gain to Start Week -- Market Talk

2025. g. 15. dec. 18:37 UTC

Tirgus saruna

Oil Futures Extend Losses On Oversupply Worries -- Market Talk

2025. g. 15. dec. 18:29 UTC

Tirgus saruna

ServiceNow Seen Facing Pressure if Government Budgets Decline -- Market Talk

2025. g. 15. dec. 17:58 UTC

Tirgus saruna

Canada Housing Market In Search Of a Bottom -- Market Talk

2025. g. 15. dec. 17:36 UTC

Tirgus saruna

Canada Data Signal Underlying Price Pressures Persist -- Market Talk

2025. g. 15. dec. 17:36 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 15. dec. 17:36 UTC

Peļņas

Texas Instruments Stock Slips. It Caught a Rare Downgrade From Goldman Sachs. -- Barrons.com

2025. g. 15. dec. 17:30 UTC

Iegādes, apvienošanās, pārņemšana

Cinemark Stock Could Fall Even More If Netflix Buys Warner Bros., Analyst Says -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

263.07% augšup

Prognoze 12 mēnešiem

Vidējais 8.75 USD 263.07%

Augstākais 12 USD

Zemākais 5.5 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.